Clinical trials

  • TH9619 for Solid tumors | Non-small cell lung cancer | Colorectal cancer | Head and neck cancer | Gastric cancer
  • ferric carboxymaltose for Chronic heart failure | Iron deficiency
  • CAGRILINTIDE for Overweight and obesity | Type 2 diabetes
  • ZIGAKIBART for IgA nephropathy
  • ENCEPHALITIS, JAPANESE, INACTIVATED, WHOLE VIRUS for Japanese encephalitis (vaccination)
  • CAGRILINTIDE for Overweight | Obesity
  • NIVOLUMAB for Peritoneal mesothelioma
  • DOTA-SIGLEC-9 labelled with Gallium-68 for Rheumatoid arthritis | Vasculitis | Pulmonary sarcoidosis
  • BI 690517 for Heart failure
  • CUSP06 for Advanced renal cell carcinoma | Platinum-resistant ovarian cancer | CDH6-positive advanced solid tumors
  • PF-08049820 for Atopic dermatitis
  • ATEZOLIZUMAB for Metastatic triple-negative breast cancer (PD-L1 positive)